;PMID: 12021900
;source_file_699.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..46] = [t:0..46]
;1)sentence:[e:51..183] = [t:51..183]
;2)section:[e:187..194] = [t:187..194]
;3)section:[e:198..308] = [t:198..308]
;4)sentence:[e:312..331] = [t:312..331]
;5)sentence:[e:332..426] = [t:332..426]
;6)sentence:[e:427..561] = [t:427..561]
;7)sentence:[e:562..707] = [t:562..707]
;8)sentence:[e:708..716] = [t:708..716]
;9)sentence:[e:717..950] = [t:717..950]
;10)sentence:[e:951..1067] = [t:951..1067]
;11)sentence:[e:1068..1076] = [t:1068..1076]
;12)sentence:[e:1077..1209] = [t:1077..1209]
;13)sentence:[e:1210..1304] = [t:1210..1304]
;14)sentence:[e:1305..1363] = [t:1305..1363]
;15)sentence:[e:1364..1480] = [t:1364..1480]
;16)sentence:[e:1481..1604] = [t:1481..1604]
;17)sentence:[e:1605..1617] = [t:1605..1617]
;18)sentence:[e:1618..1809] = [t:1618..1809]
;19)section:[e:1813..1858] = [t:1813..1858]

;section 0 Span:0..46
;J Hepatobiliary Pancreat Surg  2002;9(1):76-85
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..15] Hepatobiliary) (NNP:[16..24] Pancreat)
        (NNP:[25..29] Surg) (CC:[31..38] 2002;9-LRB-) (CD:[38..39] 1)
        (-RRB-:[39..40] -RRB-) (CD:[40..43] :76) (::[43..44] -) (CD:[44..46] 85)))

;sentence 1 Span:51..183
;p16 and p53 gene alterations and accumulations in the malignant evolution of 
;intraductal papillary-mucinous tumors of the pancreas.
;[51..54]:gene-rna:"p16"
;[59..62]:gene-rna:"p53"
;[129..182]:malignancy:"intraductal papillary-mucinous tumors of the
;pancreas"
(SENT
  (NP-HLN
    (NP
      (NP (NN:[51..54] p16)
        (NML-2 (-NONE-:[54..54] *P*)))
      (CC:[55..58] and)
      (NP (NN:[59..62] p53)
        (NML-2
          (NML
            (NML-1 (NN:[63..67] gene))
            (NNS:[68..79] alterations))
          (CC:[80..83] and)
          (NML
            (NML-1 (-NONE-:[83..83] *P*))
            (NNS:[84..97] accumulations)))))
    (PP (IN:[98..100] in)
      (NP
        (NP (DT:[101..104] the) (JJ:[105..114] malignant)
            (NN:[115..124] evolution))
        (PP (IN:[125..127] of)
          (NP
            (NP (JJ:[129..140] intraductal)
              (ADJP (JJ:[141..150] papillary) (HYPH:[150..151] -)
                    (JJ:[151..159] mucinous))
              (NNS:[160..166] tumors))
            (PP (IN:[167..169] of)
              (NP (DT:[170..173] the) (NN:[174..182] pancreas)))))))
    (.:[182..183] .)))

;section 2 Span:187..194
;Wada K.
(SEC
  (FRAG (NNP:[187..191] Wada) (NNP:[192..194] K.)))

;section 3 Span:198..308
;Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, 
;Itabashi-ku, Tokyo 173-8605, Japan.
(SEC
  (FRAG (NNP:[198..208] Department) (IN:[209..211] of) (NNP:[212..219] Surgery)
        (,:[219..220] ,) (NNP:[221..227] Teikyo) (NNP:[228..238] University)
        (NNP:[239..245] School) (IN:[246..248] of) (NNP:[249..257] Medicine)
        (,:[257..258] ,) (CD:[259..260] 2) (::[260..261] -) (CD:[261..263] 11)
        (::[263..264] -) (CD:[264..265] 1) (NN:[266..270] Kaga) (,:[270..271] ,)
        (NNP:[273..281] Itabashi) (::[281..282] -) (NN:[282..284] ku)
        (,:[284..285] ,) (NNP:[286..291] Tokyo) (CD:[292..295] 173)
        (::[295..296] -) (CD:[296..300] 8605) (,:[300..301] ,)
        (NNP:[302..307] Japan) (.:[307..308] .)))

;sentence 4 Span:312..331
;BACKGROUND/PURPOSE:
(SENT
  (NP (NN:[312..322] BACKGROUND) (SYM:[322..323] /) (NN:[323..330] PURPOSE)
      (::[330..331] :)))

;sentence 5 Span:332..426
;In general, intraductal papillary-mucinous tumors of the  pancreas have a
;favorable prognosis.
;[344..398]:malignancy:"intraductal papillary-mucinous tumors of the 
;pancreas"
(SENT
  (S
    (PP (IN:[332..334] In)
      (ADJP (JJ:[335..342] general)))
    (,:[342..343] ,)
    (NP-SBJ
      (NP (JJ:[344..355] intraductal)
        (NML (JJ:[356..365] papillary) (HYPH:[365..366] -)
             (JJ:[366..374] mucinous))
        (NNS:[375..381] tumors))
      (PP (IN:[382..384] of)
        (NP (DT:[385..388] the) (NN:[390..398] pancreas))))
    (VP (VBP:[399..403] have)
      (NP (DT:[404..405] a) (JJ:[406..415] favorable) (NN:[416..425] prognosis)))
    (.:[425..426] .)))

;sentence 6 Span:427..561
;However, some invasive carcinomas show a  rapid progression and a poor
;prognosis, such as invasive ductal carcinomas of  the pancreas.
;[441..460]:malignancy:"invasive carcinomas"
;[517..560]:malignancy:"invasive ductal carcinomas of  the pancreas"
(SENT
  (S
    (ADVP (RB:[427..434] However))
    (,:[434..435] ,)
    (NP-SBJ
      (NP (DT:[436..440] some)
         (JJ:[441..449] invasive) (NNS:[450..460] carcinomas))
      (PP-1 (-NONE-:[460..460] *ICH*)))
    (VP (VBP:[461..465] show)
      (NP
        (NP (DT:[466..467] a) (JJ:[469..474] rapid) (NN:[475..486] progression))
        (CC:[487..490] and)
        (NP (DT:[491..492] a) (JJ:[493..497] poor) (NN:[498..507] prognosis)))
      (,:[507..508] ,)
      (PP-1 (JJ:[509..513] such) (IN:[514..516] as)
        (NP
          (NP (JJ:[517..525] invasive) (JJ:[526..532] ductal)
              (NNS:[533..543] carcinomas))
          (PP (IN:[544..546] of)
            (NP (DT:[548..551] the) (NN:[552..560] pancreas))))))
    (.:[560..561] .)))

;sentence 7 Span:562..707
;The aim of this study was to clarify the genetic backgrounds  underlying the
;evolution necessary for these tumors to become invasive  carcinomas.
;[669..675]:malignancy:"tumors"
;[686..706]:malignancy:"invasive  carcinomas"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[562..565] The) (NN:[566..569] aim))
      (PP (IN:[570..572] of)
        (NP (DT:[573..577] this) (NN:[578..583] study))))
    (VP (VBD:[584..587] was)
      (S-PRP-PRD
        (NP-SBJ (-NONE-:[587..587] *))
        (VP (TO:[588..590] to)
          (VP (VB:[591..598] clarify)
            (NP
              (NP (DT:[599..602] the) (JJ:[603..610] genetic)
                  (NNS:[611..622] backgrounds))
              (VP (VBG:[624..634] underlying)
                (NP (DT:[635..638] the) (NN:[639..648] evolution)
                    (JJ:[649..658] necessary)
                  (SBAR (IN:[659..662] for)
                    (S
                      (NP-SBJ (DT:[663..668] these) (NNS:[669..675] tumors))
                      (VP (TO:[676..678] to)
                        (VP (VB:[679..685] become)
                          (NP-PRD (JJ:[686..694] invasive)
                                  (NNS:[696..706] carcinomas)))))))))))))
    (.:[706..707] .)))

;sentence 8 Span:708..716
;METHODS:
(SENT
  (NP (NNS:[708..715] METHODS) (::[715..716] :)))

;sentence 9 Span:717..950
;Twenty-three patients with intraductal papillary-mucinous  tumors, including
;9 adenomas, 5 borderline tumors, 3 noninvasive carcinomas, and  6 invasive
;carcinomas, along with 24 patients with invasive ductal carcinomas  were
;studied.
;[744..782]:malignancy:"intraductal papillary-mucinous  tumors"
;[796..804]:malignancy:"adenomas"
;[808..825]:malignancy:"borderline tumors"
;[829..851]:malignancy:"noninvasive carcinomas"
;[860..879]:malignancy:"invasive carcinomas"
;[909..935]:malignancy:"invasive ductal carcinomas"
(SENT
  (S
    (NP-SBJ-1
      (NP (CD:[717..729] Twenty-three) (NNS:[730..738] patients))
      (PP (IN:[739..743] with)
        (NP
          (NP (JJ:[744..755] intraductal)
            (ADJP (JJ:[756..765] papillary) (HYPH:[765..766] -)
                  (JJ:[766..774] mucinous))
            (NNS:[776..782] tumors))
          (,:[782..783] ,)
          (PP (VBG:[784..793] including)
            (NP
              (NP (CD:[794..795] 9) (NNS:[796..804] adenomas))
              (,:[804..805] ,)
              (NP (CD:[806..807] 5)
                 (JJ:[808..818] borderline) (NNS:[819..825] tumors))
              (,:[825..826] ,)
              (NP (CD:[827..828] 3)
                 (JJ:[829..840] noninvasive) (NNS:[841..851] carcinomas))
              (,:[851..852] ,) (CC:[853..856] and)
              (NP (CD:[858..859] 6)
                 (JJ:[860..868] invasive) (NNS:[869..879] carcinomas))))))
      (,:[879..880] ,)
      (PP (IN:[881..886] along)
        (PP (IN:[887..891] with)
          (NP
            (NP (CD:[892..894] 24) (NNS:[895..903] patients))
            (PP (IN:[904..908] with)
              (NP (JJ:[909..917] invasive) (JJ:[918..924] ductal)
                  (NNS:[925..935] carcinomas)))))))
    (VP (VBD:[937..941] were)
      (VP (VBN:[942..949] studied)
        (NP-1 (-NONE-:[949..949] *))))
    (.:[949..950] .)))

;sentence 10 Span:951..1067
;After microdissection, K- ras mutation and loss of heterozygosity  (LOH) of
;the p16 and p53 genes were investigated.
;[974..980]:gene-rna:"K- ras"
;[994..1016]:variation-type:"loss of heterozygosity"
;[1019..1022]:variation-type:"LOH"
;[1031..1034]:gene-rna:"p16"
;[1039..1042]:gene-rna:"p53"
(SENT
  (S
    (PP-TMP (IN:[951..956] After)
      (NP (NN:[957..972] microdissection)))
    (,:[972..973] ,)
    (NP-SBJ-2
      (NP
        (NP
          (NML (NN:[974..975] K) (HYPH:[975..976] -) (NN:[977..980] ras))
          (NN:[981..989] mutation))
        (CC:[990..993] and)
        (NP
          (NP
            (NP (NN:[994..998] loss))
            (PP (IN:[999..1001] of)
              (NP (NN:[1002..1016] heterozygosity))))
          (NP (-LRB-:[1018..1019] -LRB-) (NN:[1019..1022] LOH)
              (-RRB-:[1022..1023] -RRB-))))
      (PP (IN:[1024..1026] of)
        (NP (DT:[1027..1030] the)
          (NML
            (NML (NN:[1031..1034] p16)
              (NML-1 (-NONE-:[1034..1034] *P*)))
            (CC:[1035..1038] and)
            (NML (NN:[1039..1042] p53)
              (NML-1 (NNS:[1043..1048] genes)))))))
    (VP (VBD:[1049..1053] were)
      (VP (VBN:[1054..1066] investigated)
        (NP-2 (-NONE-:[1066..1066] *))))
    (.:[1066..1067] .)))

;sentence 11 Span:1068..1076
;RESULTS:
(SENT
  (NP (NNS:[1068..1075] RESULTS) (::[1075..1076] :)))

;sentence 12 Span:1077..1209
;In the intraductal  papillary-mucinous tumors, K- ras mutations were
;frequently seen, without a  relationship to histological grade.
;[1084..1122]:malignancy:"intraductal  papillary-mucinous tumors"
;[1124..1130]:gene-rna:"K- ras"
(SENT
  (S
    (PP (IN:[1077..1079] In)
      (NP (DT:[1080..1083] the)
         (JJ:[1084..1095] intraductal)
        (NML (JJ:[1097..1106] papillary) (HYPH:[1106..1107] -)
             (JJ:[1107..1115] mucinous))
        (NNS:[1116..1122] tumors)))
    (,:[1122..1123] ,)
    (NP-SBJ-1
      (NML (NN:[1124..1125] K) (HYPH:[1125..1126] -) (NN:[1127..1130] ras))
      (NNS:[1131..1140] mutations))
    (VP (VBD:[1141..1145] were)
      (ADVP-TMP (RB:[1146..1156] frequently))
      (VP (VBN:[1157..1161] seen)
        (NP-1 (-NONE-:[1161..1161] *))
        (,:[1161..1162] ,)
        (PP (IN:[1163..1170] without)
          (NP
            (NP (DT:[1171..1172] a) (NN:[1174..1186] relationship))
            (PP (TO:[1187..1189] to)
              (NP (JJ:[1190..1202] histological) (NN:[1203..1208] grade)))))))
    (.:[1208..1209] .)))

;sentence 13 Span:1210..1304
;LOH of the p16 gene was observed  increasingly with increasing degrees of
;histological atypia.
;[1210..1213]:variation-type:"LOH"
;[1221..1224]:gene-rna:"p16"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[1210..1213] LOH))
      (PP (IN:[1214..1216] of)
        (NP (DT:[1217..1220] the) (NN:[1221..1224] p16) (NN:[1225..1229] gene))))
    (VP (VBD:[1230..1233] was)
      (VP (VBN:[1234..1242] observed)
        (NP-1 (-NONE-:[1242..1242] *))
        (ADVP (RB:[1244..1256] increasingly))
        (PP (IN:[1257..1261] with)
          (NP
            (NP (VBG:[1262..1272] increasing) (NNS:[1273..1280] degrees))
            (PP (IN:[1281..1283] of)
              (NP (JJ:[1284..1296] histological) (NN:[1297..1303] atypia)))))))
    (.:[1303..1304] .)))

;sentence 14 Span:1305..1363
;LOH of the p53 gene  was seen only in invasive carcinomas.
;[1305..1308]:variation-type:"LOH"
;[1316..1319]:gene-rna:"p53"
;[1343..1362]:malignancy:"invasive carcinomas"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[1305..1308] LOH))
      (PP (IN:[1309..1311] of)
        (NP (DT:[1312..1315] the) (NN:[1316..1319] p53) (NN:[1320..1324] gene))))
    (VP (VBD:[1326..1329] was)
      (VP (VBN:[1330..1334] seen)
        (NP-1 (-NONE-:[1334..1334] *))
        (PP-LOC (RB:[1335..1339] only) (IN:[1340..1342] in)
          (NP (JJ:[1343..1351] invasive) (NNS:[1352..1362] carcinomas)))))
    (.:[1362..1363] .)))

;sentence 15 Span:1364..1480
;The frequency of each genetic alteration  in invasive carcinomas was the same
;as that in invasive ductal carcinomas.
;[1409..1428]:malignancy:"invasive carcinomas"
;[1453..1479]:malignancy:"invasive ductal carcinomas"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1364..1367] The) (NN:[1368..1377] frequency))
      (PP (IN:[1378..1380] of)
        (NP (DT:[1381..1385] each) (JJ:[1386..1393] genetic)
            (NN:[1394..1404] alteration)))
      (PP-LOC (IN:[1406..1408] in)
        (NP (JJ:[1409..1417] invasive) (NNS:[1418..1428] carcinomas))))
    (VP (VBD:[1429..1432] was)
      (NP-PRD
        (NP (DT:[1433..1436] the) (JJ:[1437..1441] same))
        (PP (IN:[1442..1444] as)
          (NP
            (NP (DT:[1445..1449] that))
            (PP (IN:[1450..1452] in)
              (NP (JJ:[1453..1461] invasive) (JJ:[1462..1468] ductal)
                  (NNS:[1469..1479] carcinomas)))))))
    (.:[1479..1480] .)))

;sentence 16 Span:1481..1604
;The  accumulation of genetic alterations was as common in invasive
;carcinomas, as  they were in invasive ductal carcinomas.
;[1539..1558]:malignancy:"invasive carcinomas"
;[1577..1603]:malignancy:"invasive ductal carcinomas"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1481..1484] The) (NN:[1486..1498] accumulation))
      (PP (IN:[1499..1501] of)
        (NP (JJ:[1502..1509] genetic) (NNS:[1510..1521] alterations))))
    (VP (VBD:[1522..1525] was)
      (ADJP-PRD
        (ADJP (RB:[1526..1528] as) (JJ:[1529..1535] common))
        (PP-LOC (IN:[1536..1538] in)
          (NP (JJ:[1539..1547] invasive) (NNS:[1548..1558] carcinomas)))
        (,:[1558..1559] ,)
        (SBAR (IN:[1560..1562] as)
          (S
            (NP-SBJ (PRP:[1564..1568] they))
            (VP (VBD:[1569..1573] were)
              (PP-LOC-PRD (IN:[1574..1576] in)
                (NP (JJ:[1577..1585] invasive) (JJ:[1586..1592] ductal)
                    (NNS:[1593..1603] carcinomas))))))))
    (.:[1603..1604] .)))

;sentence 17 Span:1605..1617
;CONCLUSIONS:
(SENT
  (NP (NNS:[1605..1616] CONCLUSIONS) (::[1616..1617] :)))

;sentence 18 Span:1618..1809
;The p16 and p53 gene  alterations and accumulations observed are crucial
;events during the  carcinogenesis and malignant progression of intraductal
;papillary-mucinous  tumors of the pancreas.
;[1622..1625]:gene-rna:"p16"
;[1630..1633]:gene-rna:"p53"
;[1754..1808]:malignancy:"intraductal papillary-mucinous  tumors of the
;pancreas"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1618..1621] The)
        (NML
          (NML (NN:[1622..1625] p16)
            (NML-2 (-NONE-:[1625..1625] *P*)))
          (CC:[1626..1629] and)
          (NML-2 (NN:[1630..1633] p53)
            (NML
              (NML
                (NML-1 (NN:[1634..1638] gene))
                (NNS:[1640..1651] alterations))
              (CC:[1652..1655] and)
              (NML
                (NML-1 (-NONE-:[1655..1655] *P*))
                (NNS:[1656..1669] accumulations))))))
      (VP (VBN:[1670..1678] observed)
        (NP (-NONE-:[1678..1678] *))))
    (VP (VBP:[1679..1682] are)
      (NP-PRD (JJ:[1683..1690] crucial) (NNS:[1691..1697] events))
      (PP-TMP (IN:[1698..1704] during)
        (NP
          (NP (DT:[1705..1708] the)
            (NML
              (NML (NN:[1710..1724] carcinogenesis))
              (CC:[1725..1728] and)
              (NML (JJ:[1729..1738] malignant) (NN:[1739..1750] progression))))
          (PP (IN:[1751..1753] of)
            (NP
              (NP (JJ:[1754..1765] intraductal)
                (ADJP (JJ:[1766..1775] papillary) (HYPH:[1775..1776] -)
                      (JJ:[1776..1784] mucinous))
                (NNS:[1786..1792] tumors))
              (PP (IN:[1793..1795] of)
                (NP (DT:[1796..1799] the) (NN:[1800..1808] pancreas))))))))
    (.:[1808..1809] .)))

;section 19 Span:1813..1858
;PMID: 12021900 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1813..1817] PMID) (::[1817..1818] :) (CD:[1819..1827] 12021900)
        (NN:[1828..1829] -LSB-) (NNP:[1829..1835] PubMed) (::[1836..1837] -)
        (NN:[1838..1845] indexed) (IN:[1846..1849] for)
        (NNP:[1850..1858] MEDLINE-RSB-)))
